David Watson - 20 Jan 2023 Form 4 Insider Report for Apellis Pharmaceuticals, Inc. (APLS)

Role
General Counsel
Signature
David Watson
Issuer symbol
APLS
Transactions as of
20 Jan 2023
Transactions value $
-$105,870
Form type
4
Filing time
24 Jan 2023, 16:33:28 UTC
Previous filing
17 Jan 2023
Next filing
30 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APLS Common Stock Tax liability -$106K -2.03K -1.2% $52.05 167K 20 Jan 2023 Direct F1
holding APLS Common Stock 3.33K 20 Jan 2023 Indirect Owner (Custodial Account for Son) F2
holding APLS Common Stock 6.67K 20 Jan 2023 Indirect Owner (The Watson Education Trust) F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This represents shares withheld for tax on a restricted stock unit release.
F2 This represents a custodial account held by the reporting person for the sole benefit of his minor son.
F3 The securities are held by The Watson Education Trust (the "Trust"), for which the reporting person serves as trustee. The reporting person disclaims beneficial ownership over the shares held by the Trust except to the extent of his pecuniary interest therein.